← The Wire
ADPTNasdaq
Adaptive Biotechnologies Corp
Biological Products, (No Diagnostic Substances) · WA · CIK 1478320
They decode the adaptive immune system to transform disease diagnosis and treatment
$2.82B
Market cap
$21.40
Last close
+2.1%
1D
+23.2%
5D
3.5M
Volume
Price · last 39 sessions+47.6%
May 4L $12.71 · H $21.40Jun 29
136
Total filings
Jun 22, 2026
Last filing
12/31
Fiscal year end
8-KMaterial Agreement · Agreement TerminatedJun 22, 20268-KCompany UpdateJun 15, 20268-KShareholder VoteJun 9, 202610-Q10-QMay 5, 20268-KResults of OperationsMay 5, 2026DEFA14ADEFA14AApr 24, 2026DEF 14ADEF 14AApr 24, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 5, 20268-KResults of Operations · Reg FD DisclosureJan 12, 20268-KCompany UpdateDec 30, 202510-Q10-QNov 5, 20258-KResults of OperationsNov 5, 20258-KAgreement TerminatedAug 18, 202510-Q10-QAug 5, 20258-KResults of OperationsAug 5, 20258-KShareholder VoteJun 12, 202510-Q10-QMay 1, 20258-KResults of OperationsMay 1, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 202510-K10-KMar 3, 20258-KResults of OperationsFeb 11, 2025SC 13GSC 13GNov 13, 2024SC 13GSC 13GNov 8, 202410-Q10-QNov 7, 20248-KResults of OperationsNov 7, 2024SC 13GSC 13GNov 5, 2024SC 13GSC 13GNov 4, 202410-Q10-QAug 1, 20248-KResults of OperationsAug 1, 20248-KShareholder Vote · Company UpdateJun 11, 2024SC 13GSC 13GMay 28, 2024DEFA14ADEFA14AMay 24, 202410-Q10-QMay 7, 20248-KResults of OperationsMay 7, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 20248-KExecutive ChangeApr 9, 20248-KResults of OperationsApr 5, 20248-KExecutive ChangeApr 2, 202410-K10-KFeb 29, 20248-KResults of OperationsFeb 14, 2024SC 13GSC 13GJan 26, 202410-Q10-QNov 9, 20238-KResults of OperationsNov 9, 20238-KExecutive ChangeSep 1, 202310-Q10-QAug 2, 20238-KExecutive Change · Results of OperationsAug 2, 20238-KDelisting NoticeJul 3, 20238-KExecutive Change · Shareholder VoteJun 13, 2023DEFA14ADEFA14AJun 1, 20238-KReg FD Disclosure · Company UpdateMay 9, 202310-Q10-QMay 3, 20238-KResults of OperationsMay 3, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 20238-KExecutive ChangeApr 11, 202310-K10-KFeb 14, 20238-KResults of OperationsFeb 14, 2023SC 13GSC 13GFeb 13, 2023SC 13GSC 13GFeb 10, 202310-Q10-QNov 3, 20228-KResults of OperationsNov 3, 20228-KMaterial Agreement · New Debt / ObligationSep 12, 202210-Q10-QAug 3, 20228-KResults of OperationsAug 3, 20228-KShareholder VoteJun 14, 202210-Q10-QMay 4, 20228-KResults of OperationsMay 4, 2022DEFA14ADEFA14AApr 22, 2022DEF 14ADEF 14AApr 22, 20228-KCompany UpdateMar 25, 20228-KExecutive ChangeMar 11, 202210-K10-KFeb 15, 20228-KExecutive Change · Results of OperationsFeb 15, 2022SC 13GSC 13GFeb 10, 20228-KExecutive Change · Results of OperationsJan 10, 202210-Q10-QNov 3, 20218-KExecutive Change · Results of OperationsNov 3, 2021
Insider Activity
In the 90 days to Mar 31, 2026: 8 sold $39.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 31, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $13.45 | $256K |
| Mar 30, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $12.63 | $241K |
| Mar 27, 2026 | Rubinstein JuliePresident and COO | Sell | 16,322 | $13.48 | $220K |
| Mar 27, 2026 | Rubinstein JuliePresident and COO | Sell | 2,738 | $12.49 | $34K |
| Mar 26, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $14.12 | $269K |
| Mar 25, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $14.27 | $272K |
| Mar 24, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $13.70 | $261K |
| Mar 23, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $13.83 | $264K |
| Mar 20, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $13.37 | $255K |
| Mar 19, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $13.18 | $251K |
| Mar 18, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $13.18 | $251K |
| Mar 17, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $13.40 | $255K |
| Mar 16, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $13.41 | $256K |
| Mar 13, 2026 | Rubinstein JuliePresident and COO | Sell | 19,060 | $12.96 | $247K |
| Mar 12, 2026 | Rubinstein JuliePresident and COO | Sell | 13,660 | $12.63 | $173K |
| Mar 12, 2026 | Rubinstein JuliePresident and COO | Sell | 5,400 | $13.43 | $73K |
| Mar 11, 2026 | Robins Harlan SChief Scientific Officer | Sell | 329,600 | $13.17 | $4.3M |
| Mar 11, 2026 | Robins Chad MCEO and Chairman | Sell | 329,600 | $13.17 | $4.3M |
| Mar 11, 2026 | Robins Harlan SChief Scientific Officer | Sell | 140,666 | $13.17 | $1.9M |
| Mar 11, 2026 | Robins Chad MCEO and Chairman | Sell | 140,567 | $13.17 | $1.9M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance